March 13, 2019 09:00 AM EDT
People
Pharma

End­points News poll: In­dus­try in­sid­ers of­fer a big 👍 for Ned Sharp­less

John Carroll

Editor & Founder

We ran a snap poll on the news that NCI chief Ned Sharp­less was named the act­ing com­mis­sion­er at the FDA as the pop­u­lar …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Sage sues Bio­gen days af­ter $469M buy­out of­fer

An­oth­er US biotech emerges with drug can­di­date from Chi­na-based Keymed

Sion­na and Odyssey end JPM week with IPO fil­ings

FDA ap­proves As­traZeneca and Dai­ichi Sankyo’s ADC for breast can­cer de­spite lack of sur­vival ben­e­fit

Ozem­pic makes list for next round of Medicare drug price ne­go­ti­a­tions

sponsored

Fu­el­ing More Break­throughs: Man­u­fac­tur­ing In­no­va­tion to Ex­pand Gene Ther­a­py’s Reach

A service from the Financial Times